Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2 Suppl 1
pubmed:dateCreated
2006-1-24
pubmed:abstractText
Frameshift (+1) proteins such as APP(+1) and UBB(+1) accumulate in sporadic cases of Alzheimer disease (AD) and in older subjects with Down syndrome (DS). We investigated whether these proteins also accumulate at an early stage of neuropathogenesis in young DS individuals without neuropathology and in early-onset familial forms of AD (FAD), as well as in other tauopathies, such as Pick disease (PiD) or progressive supranuclear palsy (PSP). APP(+1) is present in many neurons and beaded neurites in very young cases of DS, which suggests that it is axonally transported. In older DS patients (>37 years), a mixed pattern of APP(+1) immunoreactivity was observed in healthy looking neurons and neurites, dystrophic neurites, in association with neuritic plaques, as well as neurofibrillary tangles. UBB(+1) immunoreactivity was exclusively present in AD type of neuropathology. A similar pattern of APP(+1) and UBB(+1) immunoreactivity was also observed for FAD and much less explicit in nondemented controls after the age of 51 years. Furthermore, we observed accumulation of +1 proteins in other types of tauopathies, such as PiD, frontotemporal dementia, PSP and argyrophylic grain disease. These data suggest that accumulation of +1 proteins contributes to the early stages of dementia and plays a pathogenic role in a number of diseases that involve the accumulation of tau.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1526-632X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
24
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S86-92
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16432153-Adult, pubmed-meshheading:16432153-Aged, pubmed-meshheading:16432153-Aged, 80 and over, pubmed-meshheading:16432153-Alzheimer Disease, pubmed-meshheading:16432153-Amino Acid Substitution, pubmed-meshheading:16432153-Amyloid beta-Protein Precursor, pubmed-meshheading:16432153-Cerebral Cortex, pubmed-meshheading:16432153-Down Syndrome, pubmed-meshheading:16432153-Female, pubmed-meshheading:16432153-Frameshift Mutation, pubmed-meshheading:16432153-Genes, Dominant, pubmed-meshheading:16432153-Hippocampus, pubmed-meshheading:16432153-Humans, pubmed-meshheading:16432153-Immunoenzyme Techniques, pubmed-meshheading:16432153-Male, pubmed-meshheading:16432153-Membrane Proteins, pubmed-meshheading:16432153-Middle Aged, pubmed-meshheading:16432153-Nerve Degeneration, pubmed-meshheading:16432153-Pedigree, pubmed-meshheading:16432153-Presenilin-1, pubmed-meshheading:16432153-Tauopathies, pubmed-meshheading:16432153-Ubiquitin
pubmed:year
2006
pubmed:articleTitle
Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies.
pubmed:affiliation
The Netherlands Institute for Brain Research, Graduate School Neurosciences Amsterdam, Amsterdam, The Netherlands. f.van.leeuwen@nih.knaw.nl
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't